Found: 22
Select item for more details and to access through your institution.
Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 6, p. 463, doi. 10.1002/ajh.23433
- By:
- Publication type:
- Article
EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4519, doi. 10.3390/cancers15184519
- By:
- Publication type:
- Article
Two States of Myeloma Stem Cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 1, p. 6, doi. 10.1002/ajh.21310
- By:
- Publication type:
- Article
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 831, doi. 10.1002/ajh.20961
- By:
- Publication type:
- Article
利用患者骨髓瘤细胞建立NOD/SCID小鼠多发性骨髓瘤模型.
- Published in:
- Journal of Xi'an Jiaotong University (Medical Sciences), 2015, v. 36, n. 4, p. 483, doi. 10.7652/jdyxb201504011
- By:
- Publication type:
- Article
The Role of the Proteasome in Bone Formation and Osteoclastogenesis.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 6, p. 1261, doi. 10.1002/jbmr.3111
- By:
- Publication type:
- Article
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 8, p. 1635, doi. 10.1002/jbmr.1620
- By:
- Publication type:
- Article
Mesenchymal stem cells gene signature in high‐risk myeloma bone marrow linked to suppression of distinct IGFBP2‐expressing small adipocytes.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 578, doi. 10.1111/bjh.15669
- By:
- Publication type:
- Article
Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074191
- By:
- Publication type:
- Article
Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015233
- By:
- Publication type:
- Article
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Response to Bortezomib and Activation of Osteoblasts in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 109
- By:
- Publication type:
- Article
Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone.
- Published in:
- Stem Cells, 2011, v. 29, n. 2, p. 263, doi. 10.1002/stem.572
- By:
- Publication type:
- Article
Advances in the understanding of myeloma bone disease and tumour growth.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 311, doi. 10.1111/j.1365-2141.2010.08141.x
- By:
- Publication type:
- Article
Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 6, p. 775, doi. 10.1111/j.1365-2141.2009.07696.x
- By:
- Publication type:
- Article
Cell lines of hyperdiploid myeloma, are we there yet? – response to Chng & Fonseca.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 6, p. 802, doi. 10.1111/j.1365-2141.2007.06742.x
- By:
- Publication type:
- Article
Fibroblast activation protein ( FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 1, p. 83, doi. 10.1111/j.1365-2141.2006.05976.x
- By:
- Publication type:
- Article
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 1, p. 71, doi. 10.1111/j.1365-2141.2005.05733.x
- By:
- Publication type:
- Article
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 2, p. 278, doi. 10.1046/j.1365-2141.2002.03257.x
- By:
- Publication type:
- Article